Table 2.

Correlation of BET gene mRNA expression level with clinical stages of ovarian cancer patients

BET	Clinical stages	Cases	HR (95% Cl)	P-value
BRD2	I+II	135	1.78 (0.82 - 3.85)	0.14
	III+IV	1220	0.77 (0.66 - 0.89)	0.00054*
BRD3	I+II	135	2.84 (0.85 - 9.48)	0.075
	III+IV	1220	0.82 (0.7 - 0.96)	0.012*
BRD4	I+II	83	2.81 (0.97 - 8.12)	0.048*
	III+IV	487	1.23 (0.95 - 1.61)	0.12
BRDT	I+II	135	0.36 (0.16 - 0.81)	0.0097*
	III+IV	1220	0.81 (0.69 - 0.95)	0.0097*

P<0.05